Log in to save to my catalogue

IGFBP5 promotes diabetic kidney disease progression by enhancing PFKFB3-mediated endothelial glycoly...

IGFBP5 promotes diabetic kidney disease progression by enhancing PFKFB3-mediated endothelial glycoly...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3aa99a6c6f8340f3875dc3f6aa628a5d

IGFBP5 promotes diabetic kidney disease progression by enhancing PFKFB3-mediated endothelial glycolysis

About this item

Full title

IGFBP5 promotes diabetic kidney disease progression by enhancing PFKFB3-mediated endothelial glycolysis

Publisher

London: Nature Publishing Group UK

Journal title

Cell death & disease, 2022-04, Vol.13 (4), p.340-340, Article 340

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Renal inflammation is a critical pathophysiological characteristic of diabetic kidney disease (DKD). The mechanism of the inflammatory response is complicated, and there are few effective treatments for renal inflammation that can be used clinically. Insulin-like growth factor-binding protein 5 (IGFBP5) is an important secretory protein that is rel...

Alternative Titles

Full title

IGFBP5 promotes diabetic kidney disease progression by enhancing PFKFB3-mediated endothelial glycolysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3aa99a6c6f8340f3875dc3f6aa628a5d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3aa99a6c6f8340f3875dc3f6aa628a5d

Other Identifiers

ISSN

2041-4889

E-ISSN

2041-4889

DOI

10.1038/s41419-022-04803-y

How to access this item